Is There a Role for Levothyroxine Therapy in Euthyroid Patients on Active Surveillance for Papillary Microcarcinoma?
作者信息
Tuttle R Michael
机构信息
Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
出版信息
Thyroid. 2023 Oct;33(10):1137-1139. doi: 10.1089/thy.2023.0424. Epub 2023 Sep 11.
Abstract
摘要
相似文献
1
Is There a Role for Levothyroxine Therapy in Euthyroid Patients on Active Surveillance for Papillary Microcarcinoma?对于接受乳头状微小癌主动监测的甲状腺功能正常患者，左甲状腺素治疗是否有作用？
Thyroid. 2023 Oct;33(10):1137-1139. doi: 10.1089/thy.2023.0424. Epub 2023 Sep 11.
2
Re: "Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status" by Yamamoto et al.关于山本等人的《根据左甲状腺素治疗状态评估低风险甲状腺微小乳头状癌患者的主动监测结果》
Thyroid. 2024 Mar;34(3):399-400. doi: 10.1089/thy.2023.0605. Epub 2024 Feb 22.
3
Response to Xiang and Zhang re: "Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status".对 Xiang 和 Zhang 关于《根据左甲状腺素治疗状态看低风险甲状腺微小乳头状癌患者的主动监测结果》的回复
Thyroid. 2024 Mar;34(3):400-401. doi: 10.1089/thy.2023.0697. Epub 2024 Feb 13.
4
Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance.手术单独治疗甲状腺微小乳头状癌的成本更低，效果优于长期主动监测。
Surgery. 2020 Jan;167(1):110-116. doi: 10.1016/j.surg.2019.05.078. Epub 2019 Sep 19.
5
Active surveillance of low-risk papillary thyroid microcarcinoma.低风险甲状腺微小乳头状癌的主动监测
Best Pract Res Clin Endocrinol Metab. 2023 Jan;37(1):101630. doi: 10.1016/j.beem.2022.101630. Epub 2022 Feb 24.
6
[Progress in active surveillance for adult low-risk papillary thyroid microcarcinoma].[成人低风险甲状腺微小乳头状癌主动监测的进展]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Feb;37(2):150-156. doi: 10.13201/j.issn.2096-7993.2023.02.016.
7
Papillary thyroid microcarcinoma: optimal management versus overtreatment.甲状腺微小乳头状癌：最佳管理与过度治疗。
Curr Opin Oncol. 2020 Jan;32(1):1-6. doi: 10.1097/CCO.0000000000000595.
8
[Discussion on how to optimize active surveillance for low-risk papillary thyroid microcarcinoma in China].[关于如何优化中国低危甲状腺微小乳头状癌主动监测的讨论]
Zhonghua Wai Ke Za Zhi. 2023 Jun 1;61(6):462-466. doi: 10.3760/cma.j.cn112139-20221014-00442.
9
Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery.通过主动监测与立即手术治疗低风险甲状腺乳头状微小癌过程中不良事件的发生率
Thyroid. 2016 Jan;26(1):150-5. doi: 10.1089/thy.2015.0313. Epub 2015 Nov 5.
10
Observation versus thyroidectomy for papillary thyroid microcarcinoma in the elderly.老年甲状腺乳头状微小癌的观察与甲状腺切除术对比研究
J Laryngol Otol. 2017 Feb;131(2):173-176. doi: 10.1017/S0022215116009762. Epub 2016 Dec 23.
引用本文的文献
1
A decade of active surveillance for low-risk papillary thyroid carcinoma in Argentina: persistent challenges in acceptance and discontinuation rates.阿根廷对低风险乳头状甲状腺癌进行十年主动监测：接受率和终止率方面持续存在的挑战。
Endocrine. 2025 May 27. doi: 10.1007/s12020-025-04296-7.
本文引用的文献
1
Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status.根据左旋甲状腺素治疗状态，低危甲状腺微小乳头状癌患者的主动监测结果。
Thyroid. 2023 Oct;33(10):1182-1189. doi: 10.1089/thy.2023.0046. Epub 2023 Jul 5.
2
Thyroid-Stimulating Hormone, Age, and Tumor Size are Risk Factors for Progression During Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma in Adults.促甲状腺激素、年龄和肿瘤大小是成人低危甲状腺微小乳头状癌主动监测期间进展的危险因素。
World J Surg. 2023 Feb;47(2):392-401. doi: 10.1007/s00268-022-06770-z. Epub 2022 Oct 2.
3
Active Surveillance of Papillary Thyroid Cancer: Frequency and Time Course of the Six Most Common Tumor Volume Kinetic Patterns.甲状腺乳头状癌的主动监测：六种最常见肿瘤体积动力学模式的发生频率和时间进程。
Thyroid. 2022 Nov;32(11):1337-1345. doi: 10.1089/thy.2022.0325.
4
Role of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism.左甲状腺素/三碘甲状腺原氨酸联合治疗甲状腺功能减退症的作用。
Endocrinol Metab Clin North Am. 2022 Jun;51(2):243-263. doi: 10.1016/j.ecl.2021.12.003. Epub 2022 May 4.
5
Subclinical Hyperthyroidism: A Review of the Clinical Literature.亚临床甲状腺功能亢进症：临床文献综述。
Endocr Pract. 2021 Mar;27(3):254-260. doi: 10.1016/j.eprac.2021.02.002. Epub 2021 Feb 13.
6
Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.成人低危甲状腺微小乳头状癌主动监测的适应证和策略：日本内分泌外科学会甲状腺微小乳头状癌管理工作组的共识声明。
Thyroid. 2021 Feb;31(2):183-192. doi: 10.1089/thy.2020.0330. Epub 2020 Nov 2.
7
Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer.慢性淋巴细胞性甲状腺炎可降低 cN0 期甲状腺乳头状癌患者的复发风险。
Surg Oncol. 2020 Sep;34:67-73. doi: 10.1016/j.suronc.2020.03.008. Epub 2020 Apr 1.
8
A comprehensive review of randomized clinical trials in three medical journals reveals 396 medical reversals.对三家医学期刊的随机临床试验进行综合回顾，发现有 396 项医学研究结果发生了逆转。
Elife. 2019 Jun 11;8:e45183. doi: 10.7554/eLife.45183.
9
A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management.一个有助于选择分化型甲状腺癌患者进行主动监测或采用侵袭性较小的初始手术治疗的临床框架。
Expert Rev Endocrinol Metab. 2018 Mar;13(2):77-85. doi: 10.1080/17446651.2018.1449641. Epub 2018 Mar 14.
10
High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance.高血清促甲状腺激素水平与甲状腺微小乳头状癌主动监测期间的进展相关。
J Clin Endocrinol Metab. 2018 Feb 1;103(2):446-451. doi: 10.1210/jc.2017-01775.
Zotero 插件